Treatment of lichen sclerosus with antibiotics

Current therapy for lichen sclerosus centers on topical steroids, particularly clobetasol propionate. As some evidence suggests an infectious etiology owing to Borrelia, we studied the effect of penicillin and cephalosporin therapy on patients with lichen sclerosus who had responded poorly to treatment with potent topical corticosteroids.

[1]  C. Kreibich,et al.  Lichen sclerosus , 2005, Archiv für Dermatologie und Syphilis.

[2]  M. Fritzsche.  Chronic Lyme borreliosis at the root of multiple sclerosis--is a cure with antibiotics attainable? , 2005, Medical hypotheses.

[3]  F. Wojnarowska,et al.  Oxidative stress is implicated in the pathogenesis of lichen sclerosus , 2004, The British journal of dermatology.

[4]  R. Porcher,et al.  Vulvar lichen sclerosus: effect of long-term topical application of a potent steroid on the course of the disease. , 2004, Archives of dermatology.

[5]  D. Funaro.  Lichen sclerosus: a review and practical approach , 2004, Dermatologic therapy.

[6]  F. Breier,et al.  Isolation and polymerase chain reaction typing of Borrelia afzelii from a skin lesion in a seronegative patient with generalized ulcerating bullous lichen sclerosus et atrophicus , 2001, The British journal of dermatology.

[7]  J. Ring,et al.  Effect of Penicillin G on Corium Thickness in Linear Morphea of Childhood: An Analysis Using Ultrasound Technique , 1999, Pediatric dermatology.

[8]  G. von Krogh,et al.  Penile lichen sclerosus et atrophicus treated with clobetasol dipropionate 0.05% cream: a retrospective clinical and histopathological study. , 1999, Journal of the American Academy of Dermatology.

[9]  W. Shelley,et al.  Long-term antibiotic therapy for balanitis xerotica obliterans. , 1999, Journal of the American Academy of Dermatology.

[10]  N. Atabey,et al.  Evidence for Borrelia burgdorferi in morphea and lichen sclerosus. , 1998, International journal of dermatology.

[11]  R. Lange,et al.  Detection of Borrelia burgdorferi DNA (B garinii or B afzelii) in morphea and lichen sclerosus et atrophicus tissues of German and Japanese but not of US patients. , 1997, Archives of dermatology.

[12]  R. Lange,et al.  Further evidence for Borrelia burgdorferi infection in morphea and lichen sclerosus et atrophicus confirmed by DNA amplification. , 1993, The Journal of investigative dermatology.

[13]  N. Satz,et al.  [Antibiotic therapy of Lyme borreliosis]. , 1990, Schweizerische medizinische Wochenschrift.

[14]  G. Stanek,et al.  Neuroborreliosis in morphea and lichen sclerosus et atrophicus. , 1988, Journal of the American Academy of Dermatology.

[15]  E. Brehmer-Andersson,et al.  Acrodermatitis Chronica Atrophicans—A Spirochetosis Clinical and Histopathological Picture Based on 32 Patients; Course and Relationship to Erythema Chronicum Migrans Afzelius , 1986, The American Journal of dermatopathology.

[16]  Berger Bw,et al.  Spirochetes in lesions of erythema chronicum migrans. , 1982 .

[17]  O. Clemmensen,et al.  Spirochetes in lesions of erythema chronicum migrans. , 1982, The American Journal of dermatopathology.

[18]  N. Thyresson.  The penicillin treatment of acrodermatitis atrophicans chronica (Herxheimer). , 1949, Acta dermato-venereologica.